Introduction：Basic information about CAS 153101-26-9|Regavirumab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Regavirumab |
|---|
| CAS Number | 153101-26-9 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Regavirumab BiologicalActivity
| Description | Regavirumab (MCA C23) is a human monoclonal antibody against cytomegalovirus (CMV), human serum albumin (HSA) and amino acetic acid[1]. |
|---|
| Related Catalog | Research Areas >>InfectionSignaling Pathways >>Anti-infection >>CMV |
|---|
| In Vivo | 注射 Regavirumab 后获得的大鼠血清显示出强大的抑制斑块形成的活性[1]。 Regavirumab (2 mg/kg/周，5次)，第4次注射后24 h, Regavirumab 血药浓度达到稳定状态 (74.4±11.8 μg/mL)。末次注射后的消除半衰期与单次注射后相似[1]。 |
|---|
| References | [1]. Arizono H, et al. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys. Arzneimittelforschung. 1994 Jul;44(7):909-13. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
